A Practical Guide to Creating Effective Budget Impact Models
BaseCase empowers market access, medical, and sales teams to effectively engage decision-makers by translating complex…
CertaraJuly 1, 2025
The Reference-scaled Average Bioequivalence (RSABE) Approach
We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…
CertaraJuly 1, 2025
The Medicine Maker: The Biosimulation Generation
The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…
Danielle PillsburyJuly 1, 2025
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address
June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…
CertaraJune 30, 2025
Maintain & Adapt Pharma Market Access Digital Tools Using Feedback
Maintain the credibility of your pharma market access digital tools through continuous updates based on…
CertaraJune 30, 2025
The Do’s and Don’ts of Define.xml
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…
CertaraJune 27, 2025
